Less Ads, More Data, More Tools Register for FREE

Pin to quick picksLiontrust Asset Management Regulatory News (LIO)

Share Price Information for Liontrust Asset Management (LIO)

Share Price is delayed by 15 minutes
Get Live Data
306.50    -4.00 (-1.29%)
Bid:
306.00
Ask:
307.50
Spread: 1.50 (0.49%)
Market Cap: £183.25m
LIO Live PriceLast checked at - London Stock Exchange

Intraday Liontrust Asset Management Share Chart

Statement re update on documents publication

9 Jun 2023 07:00

RNS Number : 1780C
Liontrust Asset Management PLC
09 June 2023
 

THIS ANNOUNCEMENT, INCLUDING THE APPENDICES AND THE INFORMATION CONTAINED IN THEM, IS RESTRICTED AND IS NOT FOR RELEASE, PUBLICATION, DISTRIBUTION OR FORWARDING, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO JAPAN OR ANY OTHER JURISDICTION IN WHICH SUCH PUBLICATION, RELEASE OR DISTRIBUTION WOULD BE UNLAWFUL.

 

FURTHER, THIS ANNOUNCEMENT IS FOR INFORMATION PURPOSES ONLY AND IS NOT AN OFFER OF SECURITIES IN ANY JURISDICTION.

 

LEI: 549300XVXU6S7PLCL855

 

For immediate release

9 June 2023

 

Liontrust Asset Management Plc

("Liontrust" or the "Company")

Update on publication of documents for Proposed Acquisition

 

Further to the announcement by Liontrust dated 4 May 2023 in relation to the proposed acquisition of the entire issued share capital of GAM Holding AG ("GAM"), a global investment management group (the "Proposed Acquisition"), Liontrust provides an update on publication of the circular in relation to the Proposed Acquisition (the "Circular") and the Swiss offer prospectus setting out the terms and conditions of the Proposed Acquisition to the GAM shareholders (the "Swiss Offer Prospectus").

 

The Company had previously stated that it intended to publish the Circular and Swiss Offer Prospectus on 9 June 2023. The Board now expects to publish both the Circular and Swiss Offer Prospectus on or around 13 June 2023.

 

 

For further information please contact:

 

Teneo (Tel: 020 7353 4200, Email: liontrust@teneo.com)

Tom Murray or Stephanie Mackrell

 

Liontrust Asset Management Plc (Tel: 020 7412 1700, Website: liontrust.co.uk)

John Ions: Chief Executive

Vinay Abrol: Chief Financial Officer & Chief Operating Officer

Simon Hildrey: Chief Marketing Officer

David Boyle: Head of Corporate Development

 

Alantra Corporate Finance LLP (Tel: 020 7246 0500)

Lead Financial Adviser

JP McGrath, Jake Delaney, André Chetty

 

Singer Capital Markets Advisory LLP (Tel: 020 7496 3000)

Sole Sponsor, Financial Adviser and Sole Broker

Stephen Howard, Tom Salvesen, Justin McKeegan, Asha Chotai

 

Panmure Gordon (Tel: 020 7886 2500)

Corporate Broking: Stephen Jones

Corporate Advisory: Dominic Morley

 

ENDS

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
STRKVLFBXQLLBBF
Date   Source Headline
19th Nov 20219:59 amRNSForm 8.3 - National Express Group Plc
18th Nov 202111:26 amRNSForm 8.3 - National Express Group Plc
17th Nov 202111:42 amRNSForm 8.3 - National Express Group Plc
16th Nov 202111:04 amRNSForm 8.3 - National Express Group Plc
10th Nov 202111:41 amRNSForm 8.3 - National Express Group Plc
3rd Nov 202111:33 amRNSForm 8.3 - National Express Group Plc
12th Oct 202112:10 pmRNSForm 8.3 - National Express Group Plc
12th Oct 20217:00 amRNSDirectorate Change
12th Oct 20217:00 amRNSTrading Statement
5th Oct 202110:46 amRNSForm 8.3 - National Express Group Plc
30th Sep 202112:04 pmRNSForm 8.3 - National Express Group Plc
28th Sep 20212:17 pmRNSForm 8.3 - National Express Group Plc
27th Sep 20211:00 pmRNSDirector/PDMR Shareholding
23rd Sep 20213:00 pmRNSResult of AGM
26th Aug 20211:30 pmRNSForm 8.3 - Sumo Group Plc
25th Aug 20217:00 amRNSDirector/PDMR Shareholding
20th Aug 202111:24 amRNSForm 8.3 - Sumo Group Plc
19th Aug 202112:04 pmRNSForm 8.3 - Sumo Group Plc
19th Aug 20217:00 amRNSDirectorate Change
19th Aug 20217:00 amRNSNotice of AGM
18th Aug 202111:56 amRNSForm 8.3 - SUMO GROUP PLC
17th Aug 202112:45 pmRNSForm 8.3 - Sumo Group Plc
12th Aug 202111:19 amRNSForm 8.3 - Avast Plc
12th Aug 20218:00 amRNSDirector/PDMR Shareholding
11th Aug 202111:36 amRNSForm 8.3 - Science Group Plc
11th Aug 202111:33 amRNSForm 8.3 - Avast Plc
10th Aug 20213:00 pmRNSIssue of Equity
6th Aug 202110:10 amRNSForm 8.3 - Avast PLC
30th Jul 202112:53 pmRNSForm 8.3 - CHARLES STANLEY GROUP PLC
29th Jul 202110:49 amRNSForm 8.3 - Avast Plc
29th Jul 202110:46 amRNSForm 8.3 - Sumo Group Plc
28th Jul 202112:49 pmRNSForm 8.3 - SUMO GROUP PLC
28th Jul 202112:46 pmRNSForm 8.3 - AGGREKO PLC
26th Jul 202111:23 amRNSForm 8.3 - [offeree/offeror] Avast Plc
21st Jul 20219:00 amRNSHolding(s) in Company
20th Jul 202111:54 amRNSForm 8.3 - SUMO GROUP PLC
16th Jul 202112:11 pmRNSForm 8.3 - Avast Plc
15th Jul 202112:38 pmRNSForm 8.3 - AGGREKO PLC
14th Jul 202110:23 amRNSForm 8.3 - AGGREKO PLC
14th Jul 20217:00 amRNSTrading Statement
12th Jul 20217:00 amRNSHolding(s) in Company
7th Jul 20217:00 amRNSAnnual Financial Report
6th Jul 20212:41 pmRNSForm 8.3 - Ultra Electronics Holdings Plc
6th Jul 20212:38 pmRNSForm 8.3 - Renishaw Plc
6th Jul 20212:35 pmRNSForm 8.3 - Aggreko Plc
5th Jul 202111:34 amRNSForm 8.3 - GCP STUDENT LIVING PLC
29th Jun 20211:20 pmRNSForm 8.3- Ultra Electronics Holdings Plc
29th Jun 202111:00 amRNSDirector/PDMR Shareholding
28th Jun 202112:00 pmRNSIssue of Equity
24th Jun 20211:00 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.